These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24830642)

  • 21. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
    Ishigami M; Yamashita S; Sakai N; Arai T; Hirano K; Hiraoka H; Kameda-Takemura K; Matsuzawa Y
    J Biochem; 1994 Aug; 116(2):257-62. PubMed ID: 7822240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred.
    Calabresi L; Nilsson P; Pinotti E; Gomaraschi M; Favari E; Adorni MP; Bernini F; Sirtori CR; Calandra S; Franceschini G; Tarugi P
    Atherosclerosis; 2009 Aug; 205(2):506-11. PubMed ID: 19200546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a common mutation (D442G) of the cholesteryl ester transfer protein gene on lipids and lipoproteins in children.
    Arashiro R; Katsuren K; Maung KK; Fukuyama S; Ohta T
    Pediatr Res; 2001 Oct; 50(4):455-9. PubMed ID: 11568287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency.
    Arai T; Tsukada T; Murase T; Matsumoto K
    Clin Chim Acta; 2000 Nov; 301(1-2):103-17. PubMed ID: 11020466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.
    El Khoury P; Plengpanich W; Frisdal E; Le Goff W; Khovidhunkit W; Guerin M
    Atherosclerosis; 2014 May; 234(1):193-9. PubMed ID: 24674903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.
    Morton RE; Liu Y
    J Lipid Res; 2020 Aug; 61(8):1168-1179. PubMed ID: 32591337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
    Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
    Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America.
    Teh EM; Dolphin PJ; Breckenridge WC; Tan MH
    J Lipid Res; 1998 Feb; 39(2):442-56. PubMed ID: 9508004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.
    Okada T; Ohama T; Okazaki M; Kanno K; Matsuda H; Sairyo M; Zhu Y; Saga A; Kobayashi T; Masuda D; Koseki M; Nishida M; Sakata Y; Yamashita S
    PLoS One; 2018; 13(1):e0190875. PubMed ID: 29304079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abnormality of HDL subfractions in cholesteryl ester transfer protein deficiency].
    Miida T; Inano K; Nakamura Y; Matsuto T; Hoshiyama M; Kaneko K; Okada M
    Rinsho Byori; 1996 Sep; 44(9):865-70. PubMed ID: 8911072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.
    Lagrost L; Perségol L; Lallemant C; Gambert P
    J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia.
    Vigna GB; Satta E; Bernini F; Boarini S; Bosi C; Giusto L; Pinotti E; Tarugi P; Vanini A; Volpato S; Zimetti F; Zuliani G; Favari E
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):777-83. PubMed ID: 24680225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
    Cefalù AB; Noto D; Magnolo L; Pinotti E; Gomaraschi M; Martini S; Vigna GB; Calabresi L; Tarugi P; Averna MR
    Atherosclerosis; 2009 May; 204(1):202-7. PubMed ID: 18926541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The strange case of Dr HDL and Mr HDL: does a NO's story illuminate the mystery of HDL's dark side uncovered by Dr HDL's drug targeting CETP?
    Duriez P; Bordet R; Berthelot P
    Med Hypotheses; 2007; 69(4):752-7. PubMed ID: 17376606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency.
    Oliveira HC; Ma L; Milne R; Marcovina SM; Inazu A; Mabuchi H; Tall AR
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1045-52. PubMed ID: 9194753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.